Firm: All
Practice Industry: Environmental, Healthcare & Pharmaceuticals, Life Sciences
Region: All
Country/ State: All
Tag: All
Dinsmore & Shohl LLP | July 2024

The U.S. Department of Labor’s Occupational Safety and Health Administration (“OSHA”) recently cited Circles of Care, Inc., a Florida behavioral health company, for failing to provide a workplace free of recognized hazards. This citation followed an incident where a patient assaulted a mental health technician at a nurse work station ...

Dinsmore & Shohl LLP | July 2024

Recently, the Ohio General Assembly passed a bill, Substitute S.B. 40, which will enter Ohio as a party to the new Dentist and Dental Hygienist Compact, and ultimately allow dentists and hygienists practicing in other compact states to practice in Ohio. This summer, the compact will form its commission, and will continue to work on operationalizing into 2025 before officially opening privilege applications ...

Lavery Lawyers | July 2024

Greenwashing is a form of marketing that misrepresents a product, service or practice as having positive environmental effects,1 thereby misleading consumers and preventing them from making an informed purchasing decision.2 Several initiatives have been launched around the world to counter this practice. In California, a law requires business entities to disclose information in support of environmental claims ...

ALTIUS/Tiberghien | June 2024

Introduction The EU Deforestation Regulation (‘EUDR’) waspublishedin the Official Journal on 9 June 2023 and entered into force on 29 June 2023,marking the start of its implementation phase. As the EU legislator has adopted a decentralized enforcement approach, Member States need to set up the necessary legal frameworks to fulfil their enforcement duties under the EUDR ...

Dinsmore & Shohl LLP | June 2024

In a unanimous decision today, the Supreme Court rejected efforts to limit access to the abortion pill mifepristone, overturning an earlier decision by the 5th Circuit Court of Appeals. The Supreme Court ruled that the physicians and medical associations who brought the case did not have the right to challenge the FDA's regulation of the drug. To have standing, plaintiffs must show they have a “personal stake” in the case ...

Lavery Lawyers | June 2024

On December 20, 2022, the federal government's Single-Use Plastics Prohibition Regulations1 (the ?Regulations?) gradually came into force, with the effect, as the name suggests, of prohibiting (or restricting, in certain cases) the manufacture, import and sale of certain single-use plastics that pose a threat to the environment ...

Shoosmiths LLP | May 2024

Following the announcement of a UK general election, set for Thursday 4 July 2024, the real estate industry now has a unique opportunity to pro-actively engage with policymakers on sustainability – helping shape future regulation and strategy to support meeting the industry’s net zero targets ...

For many years, nurses in Ohio were only required to disclose convictions to the Ohio Board of Nursing on their biennial license renewal application. However, a new regulation from the Ohio Board of Nursing now requires licensees to additionally report a guilty plea, conviction or treatment in lieu of conviction of certain crimes within 30 days of the plea or entry ...

Han Kun Law Offices | May 2024

In recent years, the regulatory framework for human genetic resources ("HGR") in China has become increasingly mature ...

Recently, modifications announced by the Department of Health and Human Services (“HHS”) to 42 C.F.R. Part 2 (“Part 2”) rules governing Confidentiality of Substance Use Disorder (“SUD”) Patient Records went into effect. This is a major rule change for Part 2 providers and the enhanced penalties and enforcement measures make compliance with the new rules essential for any Part 2 provider ...

Shoosmiths LLP | May 2024

Last month, Shoosmiths hosted a second event with leading industry body,  Regen on REMA, The UK’s Review of Electricity Market Arrangements – Second Consultation, which closed [this week ]. The event featured insights from Dan Osgood, the director of energy markets and analysis at Department for Energy Security and Net Zero, as well as a number of expert panel discussions around the key parts of the consultation ...

Shoosmiths LLP | May 2024

Cabinet Office has developed and published a standard Carbon Reduction Contract Schedule which provides standard terms and conditions to support contract-specific decarbonisation objectives to be set and delivered and provides a framework to monitor and assess the Suppliers’ decarbonisation performance ...

Lavery Lawyers | May 2024

Greenwashing is a form of marketing that misrepresents a product, service or practice as having positive environmental effects,1 thereby misleading consumers and preventing them from making an informed purchasing decision.2 Several initiatives have been launched around the world to counter this practice. In California, a law requires business entities to disclose information in support of environmental claims ...

The United States is on the verge of one of the biggest, if not the biggest, transformations to marijuana policy in the last 50 years. According to an Associated Press report, the Drug Enforcement Administration (DEA) is expected to reschedule marijuana from a Schedule I drug to a Schedule III drug under the Controlled Substances Act (CSA) ...

Shoosmiths LLP | May 2024

Between September 2021 and May 2022, the words 'stress', 'mental health' and 'depression' appeared in more than 12,000 early conciliation or employment tribunal cases , demonstrating the prevalence of this subject matter in employment-related disputes. Today, more than ever, employers are expected to afford greater consideration to workplace conditions that do or could impact upon employees’ mental health ...

Han Kun Law Offices | May 2024

China's National Medical Products Administration (NMPA) released the 2023 Drug Review Annual Report on its official website on February 4, 2024, closely followed by the 2023 Medical Device Registration Annual Report on February 5. According to the public information, more than 60 innovative drugs have been approved by NMPA from 2022 to 2023, and a total of 61 innovative medical devices have been approved in 2023 ...

Dinsmore & Shohl LLP | April 2024

On April 23, 2024, the Federal Trade Commission (“FTC”) voted to issue a final rule banning non-compete provisions in most industries in the United States (“Final Rule”). Dinsmore attorneys were quick to publish the details and impact of the Final Rule, which is available here. This supplement focuses on the impact of the Final Rule on the healthcare industry ...

ALTIUS/Tiberghien | April 2024

On 21 September 2023,the EU Court of Justice (‘CJEU’) handed down its ruling in the Apotheke B. case (C-47/22), and it is a good example of the high threshold set by the EU Court of Justice to uphold the Community Code’s main aim of protecting public health ...

Dinsmore & Shohl LLP | April 2024

In the latest update to Kentucky’s Medical Cannabis Program (the “Program”), Governor Andy Beshear signed House Bill 829 which moved up the timeline to apply for cannabis business licenses by six months. Additionally, two emergency regulations were issued by the Program that explain how to apply for a cannabis business license ...

ALTIUS/Tiberghien | April 2024

For the past five years there has been an ongoing battle between the Belgian Competition Authority (“BCA”) and the legislator about the BCA’s competence to review mergers between hospitals. This wrangling has lead to a whole collection of legislative reforms, opinions, merger decisions with strong press releases, and communications going back and forth ...

Lavery Lawyers | March 2024

On December 6, 2023, an amendment to the Act to amend the Act respecting municipal taxation and other legislative provisions1(?Bill 39?)was adopted during a clause-by-clause consideration of Bill 39 in parliamentary committee. Two days later, the Bill received assent ...

Kudun and Partners | March 2024

Thailand’s government is on the process of launching a groundbreaking multiple-entry Medical Treatment visa (“non-MT visa“) with a generous one-year validity period, aiming to solidify its position as a premier international medical hub. The Subcommittee on Developing Thailand into a Medical Service Hub, authorized by the Ministry of Public Health, recently convened to craft the framework for this visionary visa program ...

dots